Full Text
PCN108 Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastaric Renal Cell Carcinoma in the Chinese Health Care Setting

Abstract

Authors

J. Wu N. Zhang P. Dong

Back to Volume 14, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×